Subfield- and layer-specific changes in parvalbumin, calretinin and calbindin-D28k immunoreactivity in the entorhinal cortex in Alzheimer's disease

Neuroscience

Volumn 92, Issue 2, 1999, Pages 515-532

  Mikkonen, M ^a   Alafuzoff, I ^a   Tapiola, T ^a   Soininen, H ^a   Miettinen, R ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; Calcium binding protein; GABA; Hippocampal formation; Interneurons; Parahippocampal gyrus

Indexed keywords

4 AMINOBUTYRIC ACID; CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; PARVALBUMIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; GABAERGIC SYSTEM; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERNEURON; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; SUBICULUM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; ENTORHINAL CORTEX; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE DEGENERATION; NERVE FIBERS; NEURONS; NEUROPIL; PARVALBUMINS;

EID: 0033040153     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00047-0     Document Type: Article

References (57)

1. Andressen C., Blumcke I., Celio M.R. Calcium-binding proteins: selective markers of nerve cells. Cell Tiss. Res. 271:1993;181-208.
2. Arai H., Emson P.C., Mountjoy C.Q., Carassco L.H., Heizmann C.W. Loss of parvalbumin-immunoreactive neurones from cortex in Alzheimer-type dementia. Brain Res. 418:1987;164-169.
3. Braak E., Strotkamp B., Braak H. Parvalbumin-immunoreactive structures in the hippocampus of the human adult. Cell Tiss. Res. 264:1991;33-48.
4. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta neuropath. berl. 82:1991;239-259.
5. Brady D.R., Mufson E.J. Parvalbumin-immunoreactive neurons in the hippocampal formation of Alzheimer's diseased brain. Neuroscience. 80:1997;1113-1125.
6. Brion J.P., Resibois A. A subset of calretinin-positive neurons are abnormal in Alzheimer's disease. Acta neuropath. berl. 88:1994;33-43.
7. Celio M.R., Baier W., Scharer L., de Viragh P.A., Gerday C. Monoclonal antibodies directed against the calcium binding protein parvalbumin. Cell Calcium. 9:1988;81-86.
8. Corkin S., Amaral D.G., Gonzalez R.G., Johnson K.A., Hyman B.T. H.M.'s medial temporal lobe lesion: findings from magnetic resonance imaging. J. Neurosci. 17:1997;3964-3979.
9. De Lacalle S., Lim C., Sobreviela T., Mufson E.J., Hersh L.B., Saper C.B. Cholinergic innervation in the human hippocampal formation including the entorhinal cortex. J. comp. Neurol. 345:1994;321-344.
10. DeFelipe J., Hendry S.H., Jones E.G. Synapses of double bouquet cells in monkey cerebral cortex visualized by calbindin immunoreactivity. Brain Res. 503:1989;49-54.
11. del Rio J.A., Heimrich B., Super H., Borrell V., Frotscher M., Soriano E. Differential survival of Cajal-Retzius cells in organotypic cultures of hippocampus and neocortex. J. Neurosci. 16:1996;6896-6907.
12. del Rio M.R., DeFelipe J. Colocalization of calbindin D-28k, calretinin and GABA immunoreactivities in neurons of the human temporal cortex. J. comp. Neurol. 369:1996;472-482.
13. del Rio M.R., DeFelipe J. Colocalization of parvalbumin and calbindin D-28k in neurons including chandelier cells of the human temporal neocortex. J. chem. Neuroanat. 12:1997;165-173.
14. del Rio M.R., DeFelipe J. Synaptic connections of calretinin-immunoreactive neurons in the human neocortex. J. Neurosci. 17:1997;5143-5154.
15. Du F., Whetsell W.O. Jr., Abou Khalil B., Blumenkopf B., Lothman E.W., Schwarcz R. Preferential neuronal loss in layer III of the entorhinal cortex in patients with temporal lobe epilepsy. Epilepsy Res. 16:1993;223-233.
16. Ferrer I., Soriano E., Tunon T., Fonseca M., Guionnet N. Parvalbumin immunoreactive neurons in normal human temporal neocortex and in patients with Alzheimer's disease. J. neurol. Sci. 106:1991;135-141.
17. Ferrer I., Tunon T., Soriano E., del Rio A., Iraizoz I., Fonseca M., Guionnet N. Calbindin D-28k immunoreactivity in the temporal neocortex in patients with Alzheimer's disease. Clin. Neuropath. 12:1993;53-58.
18. Fonseca M., Soriano E. Calretinin-immunoreactive neurons in the normal human temporal cortex and in Alzheimer's disease. Brain Res. 691:1995;83-91.
19. Gomez Isla T., Price J.L., McKeel D.W. Jr., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16:1996;4491-4500.
20. Gulyas A.I., Hajos N., Freund T.F. Interneurons containing calretinin are specialized to control other interneurons in the rat hippocampus. J. Neurosci. 16:1996;3397-3411.
21. Hof P.R., Cox K., Young W.G., Celio M.R., Rogers J., Morrison J.H. Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease. J. Neuropath. exp. Neurol. 50:1991;451-462.
22. Hof P.R., Morrison J.H. Neocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease. Expl Neurol. 111:1991;293-301.
23. Hof P.R., Nimchinsky E.A., Celio M.R., Bouras C., Morrison J.H. Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease. Neurosci. Lett. 152:1993;145-148.
24. Hyman B.T., Van Hoesen G.W., Kromer L.J., Damasio A.R. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann. Neurol. 20:1986;472-481.
25. Iacopino A.M., Christakos S. Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc. natn. Acad. Sci. U.S.A. 87:1990;4078-4082.
26. Ichimiya Y., Emson P.C., Mountjoy C.Q., Lawson D.E., Heizmann C.W. Loss of calbindin-28K immunoreactive neurones from the cortex in Alzheimer-type dementia. Brain Res. 475:1988;156-159.
27. Ichimiya Y., Emson P.C., Mountjoy C.Q., Lawson D.E., Iizuka R. Calbindin-immunoreactive cholinergic neurones in the nucleus basalis of Meynert in Alzheimer-type dementia. Brain Res. 499:1989;402-406.
28. Inaguma Y., Shinohara H., Inagaki T., Kato K. Immunoreactive parvalbumin concentrations in parahippocampal gyrus decrease in patients with Alzheimer's disease. J. neurol. Sci. 110:1992;57-61.
29. Insausti R. Comparative anatomy of the entorhinal cortex and hippocampus in mammals. Hippocampus. 3(Spec. No.):1993;19-26.
30. Insausti R., Amaral D.G., Cowan W.M. The entorhinal cortex of the monkey: II. Cortical afferents. J. comp. Neurol. 264:1987;356-395.
31. Insausti R., Amaral D.G., Cowan W.M. The entorhinal cortex of the monkey: III. Subcortical afferents. J. comp. Neurol. 264:1987;396-408.
32. Insausti R., Herrero M.T., Witter M.P. Entorhinal cortex of the rat: cytoarchitectonic subdivisions and the origin and distribution of cortical efferents. Hippocampus. 7:1997;146-183.
33. Insausti R., Tunon T., Sobreviela T., Insausti A.M., Gonzalo L.M. The human entorhinal cortex: a cytoarchitectonic analysis. J. comp. Neurol. 355:1995;171-198.
34. Kondo M., Sumino R., Okado H. Combinations of AMPA receptor subunit expression in individual cortical neurons correlate with expression of specific calcium-binding proteins. J. Neurosci. 17:1997;1570-1581.
35. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
36. Lewis D.A., Campbell M.J., Morrison J.H. An immunohistochemical characterization of somatostatin-28 and somatostatin-281-12 in monkey prefrontal cortex. J. comp. Neurol. 248:1986;1-18.
37. Maguire Zeiss K.A., Li Z.W., Shimoda L.M., Hamill R.W. Calbindin D28k mRNA in hippocampus, superior temporal gyrus and cerebellum: comparison between control and Alzheimer disease subjects. Molec. Brain Res. 30:1995;362-366.
38. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
39. Miettinen M., Koivisto E., Riekkinen P., Miettinen R. Coexistence of parvalbumin and GABA in nonpyramidal neurons of the rat entorhinal cortex. Brain Res. 706:1996;113-122.
40. Miettinen M., Pitkänen A., Miettinen R. Distribution of calretinin-immunoreactivity in the rat entorhinal cortex: coexistence with GABA. J. comp. Neurol. 378:1997;363-378.
41. Miettinen R., Gulyas A.I., Baimbridge K.G., Jacobowitz D.M., Freund T.F. Calretinin is present in non-pyramidal cells of the rat hippocampus. II. Co-existence with other calcium binding proteins and GABA. Neuroscience. 48:1992;29-43.
42. Mikkonen M., Soininen H., Kälviäinen R., Tapiola T., Ylinen A., Vapalahti M., Paljärvi L., Pitkänen A. Remodeling of neuronal circuitries in human temporal lobe epilepsy: Increased expression of highly polysialylated NCAM in the hippocampus and the entorhinal cortex. Ann. Neurol. 44:1999;923-934.
43. Mikkonen M., Soininen H., Pitkänen A. Distribution of parvalbumin-, calretinin- and calbindin-D28k-immunoreactive neurons and fibers in the human entorhinal cortex. J. comp. Neurol. 388:1997;64-88.
44. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
45. Sampson V.L., Morrison J.H., Vickers J.C. The cellular basis for the relative resistance of parvalbumin and calretinin immunoreactive neocortical neurons to the pathology of Alzheimer's disease. Expl Neurol. 145:1997;295-302.
46. Satoh J., Tabira T., Sano M., Nakayama H., Tateishi J. Parvalbumin-immunoreactive neurons in the human central nervous system are decreased in Alzheimer's disease. Acta neuropath. berl. 81:1991;388-395.
47. Schwaller B., Buchwald P., Blumcke I., Celio M.R., Hunziker W. Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein calretinin. Cell Calcium. 14:1993;639-648.
48. Selden N., Geula C., Hersh L., Mesulam M.M. Human striatum: chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease. Neuroscience. 60:1994;621-636.
49. Solodkin A., Veldhuizen S.D., Van Hoesen G.W. Contingent vulnerability of entorhinal parvalbumin-containing neurons in Alzheimer's disease. J. Neurosci. 16:1996;3311-3321.
50. Squire L.R., Zola Morgan S. The medial temporal lobe memory system. Science. 253:1991;1380-1386.
51. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. natn. Acad. Sci. U.S.A. 76:1979;4350-4354.
52. Tunon T., Insausti R., Ferrer I., Sobreviela T., Soriano E. Parvalbumin and calbindin D-28K in the human entorhinal cortex. An immunohistochemical study. Brain Res. 589:1992;24-32.
53. Van Hoesen G., Pandya D.N. Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. I. Temporal lobe afferents. Brain Res. 95:1975;1-24.
54. Van Hoesen G., Pandya D.N., Butters N. Cortical afferents to the entorhinal cortex of the Rhesus monkey. Science. 175:1972;1471-1473.
55. Van Hoesen G., Pandya D.N., Butters N. Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. II. Frontal lobe afferents. Brain Res. 95:1975;25-38.
56. Witter M.P. Organization of the entorhinal-hippocampal system: a review of current anatomical data. Hippocampus. 3(Spec. No.):1993;33-44.
57. Witter M.P., Amaral D.G. Entorhinal cortex of the monkey: V. Projections to the dentate gyrus, hippocampus and subicular complex. J. comp. Neurol. 307:1991;437-459.